Breast Neoplasms
Conditions
Interventions
This is a randomized clinical study using systematic random sampling, consisting of two arms: G1 (Intervention Group) and G2 (Control Group). In both G1 and G2, during the first cycle of chemotherapy,
G11.427.410.698.277
Sponsors
Hospital de Câncer de Barretos - Fundação Pio XII
Hospital de Câncer de Barretos - Fundação Pio XII
Eligibility
Sex/Gender
Female
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Women with histologically confirmed breast cancer; literate; scheduled to receive adjuvant or neoadjuvant chemotherapy; aged between 18 and 85 years; with a planned minimum of 5 cycles, after signing the Informed Consent Form - ICF
Exclusion criteria
Exclusion criteria: Patients who present any type of adverse reaction to exercise during the infusion; patients who report discomfort at any stage of the study and choose to withdraw the Informed Consent Term (ICT); patients who, for any clinical reason, need to interrupt chemotherapy treatment (toxicity, anaphylactic reaction, etc)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study is expected to show that performing physical exercises (of low to moderate intensity) during the infusion of adjuvant and neoadjuvant chemotherapy in women with breast cancer will improve functionality, fatigue, NIPQ, and overall well-being compared to patients who do not engage in any physical activity during the infusion (control group). | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactBrenda Costa
Hospital do Amor - Fundação Pio XII
Outcome results
None listed